Consultant gynec oncology provides expert oversight for complex reproductive tract cancers, coordinating diagnostics from transvaginal ultrasounds to PET-CT for staging, then orchestrating therapies like neoadjuvant chemotherapy shrinking tumors for surgical feasibility. Consultations clarify options such as HIPEC for peritoneal spread or immunotherapy for MSI-high tumors, demystifying prognosis with tools like ROMA index for ovarian risk. Holistic input addresses menopausal symptoms post-treatment via hormone modulation. Dr. Munisha Sharma, a consultant gynec oncology authority, advised a patient on borderline ovarian tumors, recommending conservative surgery preserving fertility that led to healthy motherhood two years later. Her consultations incorporate genomic profiling like FoundationOne, identifying actionable mutations for precision medicine. This role educates on surveillance schedules, tailoring CA-125 trends and TVS intervals to recurrence patterns. Multidisciplinary tumor boards refine plans weekly, integrating radiology and pathology insights. Patients value her straightforward explanations of survival curves and quality-of-life metrics. Dr. Munisha Sharmas network accesses clinical trials, offering bevacizumab or olaparib upfront for high-risk cases. Virtual consults accommodate travel barriers, with e-prescriptions streamlining care. Her emphasis on psychosocial screening links to support groups, easing isolation. Compared to generalists, consultants reduce unnecessary surgeries by 30 percent through refined selection. Dr. Munisha Sharmas patient-centered model fosters trust, tracking long-term pelvic floor health post-radiation. For second opinions or pathway navigation, her expertise illuminates paths, blending seniority with innovation for empowered decisions and superior survivorship.
Dr. Munisha Sharma.All Rights Reserved © 2026
.jpeg)